188 related articles for article (PubMed ID: 16682665)
1. Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis.
Ovbiagele B; Saver JL; Lynn MJ; Chimowitz M;
Neurology; 2006 May; 66(9):1344-9. PubMed ID: 16682665
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis.
Ovbiagele B; Lynn MJ; Saver JL; Chimowitz MI;
Cerebrovasc Dis; 2007; 24(2-3):283-8. PubMed ID: 17646693
[TBL] [Abstract][Full Text] [Related]
3. Risk factor status and vascular events in patients with symptomatic intracranial stenosis.
Chaturvedi S; Turan TN; Lynn MJ; Kasner SE; Romano J; Cotsonis G; Frankel M; Chimowitz MI;
Neurology; 2007 Nov; 69(22):2063-8. PubMed ID: 18040012
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome and risk of cardiovascular events after myocardial infarction.
Levantesi G; Macchia A; Marfisi R; Franzosi MG; Maggioni AP; Nicolosi GL; Schweiger C; Tavazzi L; Tognoni G; Valagussa F; Marchioli R;
J Am Coll Cardiol; 2005 Jul; 46(2):277-83. PubMed ID: 16022955
[TBL] [Abstract][Full Text] [Related]
5. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.
Chimowitz MI; Lynn MJ; Howlett-Smith H; Stern BJ; Hertzberg VS; Frankel MR; Levine SR; Chaturvedi S; Kasner SE; Benesch CG; Sila CA; Jovin TG; Romano JG;
N Engl J Med; 2005 Mar; 352(13):1305-16. PubMed ID: 15800226
[TBL] [Abstract][Full Text] [Related]
6. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis.
Kasner SE; Chimowitz MI; Lynn MJ; Howlett-Smith H; Stern BJ; Hertzberg VS; Frankel MR; Levine SR; Chaturvedi S; Benesch CG; Sila CA; Jovin TG; Romano JG; Cloft HJ;
Circulation; 2006 Jan; 113(4):555-63. PubMed ID: 16432056
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study.
Najarian RM; Sullivan LM; Kannel WB; Wilson PW; D'Agostino RB; Wolf PA
Arch Intern Med; 2006 Jan; 166(1):106-11. PubMed ID: 16401818
[TBL] [Abstract][Full Text] [Related]
8. Impact of metabolic syndrome on future cardiovascular events in patients with first acute myocardial infarction.
Selcuk H; Temizhan A; Selcuk MT; Sen T; Maden O; Tekeli S; Sasmaz A
Coron Artery Dis; 2009 Sep; 20(6):370-5. PubMed ID: 19609207
[TBL] [Abstract][Full Text] [Related]
9. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
Persson M; Hedblad B; Nelson JJ; Berglund G
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
[TBL] [Abstract][Full Text] [Related]
10. Prediction model with metabolic syndrome to predict recurrent vascular events in patients with clinically manifest vascular diseases.
Wassink AM; van der Graaf Y; Janssen KJ; Cook NR; Visseren FL;
Eur J Prev Cardiol; 2012 Dec; 19(6):1486-95. PubMed ID: 22008749
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome and its components as risk factors for first-ever acute ischemic noncardioembolic stroke.
Maruyama K; Uchiyama S; Iwata M
J Stroke Cerebrovasc Dis; 2009; 18(3):173-7. PubMed ID: 19426885
[TBL] [Abstract][Full Text] [Related]
12. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
[TBL] [Abstract][Full Text] [Related]
13. Association between metabolic syndrome and previous ischemic lesions in patients with intracranial atherosclerotic stroke.
Park JH; Kwon HM
Clin Neurol Neurosurg; 2008 Mar; 110(3):215-21. PubMed ID: 18055103
[TBL] [Abstract][Full Text] [Related]
14. Association of the metabolic syndrome with intracranial atherosclerotic stroke.
Bang OY; Kim JW; Lee JH; Lee MA; Lee PH; Joo IS; Huh K
Neurology; 2005 Jul; 65(2):296-8. PubMed ID: 16043803
[TBL] [Abstract][Full Text] [Related]
15. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.
Atanassova PA; Chalakova NT; Dimitrov BD
Cerebrovasc Dis; 2008; 25(3):225-33. PubMed ID: 18216464
[TBL] [Abstract][Full Text] [Related]
16. The metabolic syndrome in type 2 diabetes: When does it matter?
Wong J; Molyneaux L; Constantino MI; Twigg SM; Yue DK
Diabetes Obes Metab; 2006 Nov; 8(6):690-7. PubMed ID: 17026494
[TBL] [Abstract][Full Text] [Related]
17. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.
Knuiman MW; Hung J; Divitini ML; Davis TM; Beilby JP
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):235-41. PubMed ID: 19238082
[TBL] [Abstract][Full Text] [Related]
18. The apolipoprotein B/AI ratio and the metabolic syndrome independently predict risk for myocardial infarction in middle-aged men.
Lind L; Vessby B; Sundström J
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):406-10. PubMed ID: 16306426
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine and outcome in young patients with acute coronary syndromes.
Martín-Herrero F; Martín-Moreiras J; Pabón P; Sánchez PL; Moríñigo-Muñoz JL; Jimenez-Candil J; Cruz-González I; Alberca I; González-Porras JR; Martín-Luengo C
Int J Cardiol; 2007 May; 118(2):183-8. PubMed ID: 17023077
[TBL] [Abstract][Full Text] [Related]
20. Symptomatic intracranial atherosclerotic stenoses: prevalence and prognosis in patients with acute cerebral ischemia.
Weber R; Kraywinkel K; Diener HC; Weimar C;
Cerebrovasc Dis; 2010; 30(2):188-93. PubMed ID: 20588014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
